FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joel Moake

Research Profile

Chemicals & Drugs

Disorders

Physiology

Anatomy

Phenomena

Procedures

Plasma Exchange

Co-author Network

Publications

TOP 3
Sithara S Wijeratne; Hui-Chun Yeh; Zhou Zhou; Angela L Bergeron; Eric Botello; Jing-fei Dong; Eric W Frey; Joel L Moake; Leticia Nolasco; Jay M Patel; Nancy A Turner; Ching-Hwa Kiang
Mechanical activation of a multimeric adhesive protein through domain conformational change.
Shuju Feng; Michael H Kroll; Joel L Moake; Leticia Nolasco; Vahid Afshar-Kharghan
Complement activation in thrombotic microangiopathies.
Nancy Turner; Leticia Nolasco; Joel L Moake
Generation and breakdown of soluble ultralarge von Willebrand factor multimers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joel Moake (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sithara S Wijeratne; Hui-Chun Yeh; Zhou Zhou; Angela L Bergeron; Eric Botello; Jing-fei Dong; Eric W Frey; Joel L Moake; Leticia Nolasco; Jay M Patel; Nancy A Turner; Ching-Hwa Kiang
Mechanical activation of a multimeric adhesive protein through domain conformational change.
Physical review letters 2013;110(10):108102.
2013: Shuju Feng; Michael H Kroll; Joel L Moake; Leticia Nolasco; Vahid Afshar-Kharghan
Complement activation in thrombotic microangiopathies.
British journal of haematology 2013;160(3):404-6.
2012: Nancy Turner; Leticia Nolasco; Joel L Moake
Generation and breakdown of soluble ultralarge von Willebrand factor multimers.
Seminars in thrombosis and hemostasis 2012;38(1):38-46.
2011: Junmei Chen; Adili Reheman; Francisca C Gushiken; Leticia Nolasco; Xiaoyun Fu; Joel L Moake; Heyu Ni; José A López
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
The Journal of clinical investigation 2011;121(2):593-603.
2010: H-C Yeh; Z Zhou; Huiwei Choi; S Tekeoglu; W May; Chun Wang; N Turner; F Scheiflinger; Joel L Moake; Jing-fei Dong
Disulfide bond reduction of von Willebrand factor by ADAMTS-13.
Journal of thrombosis and haemostasis : JTH 2010;8(12):2778-88.
2009: Nancy A Turner; Leticia Nolasco; Zaverio M Ruggeri; Joel L Moake
Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage.
Blood 2009;114(24):5102-11.
2009: Zhou Zhou; Hua Jing; Zhenyin Tao; Huiwan Choi; Khatira Aboulfatova; Joel L Moake; Renhao Li; Jing-fei Dong
Effects of naturally occurring mutations in CUB-1 domain on synthesis, stability, and activity of ADAMTS-13.
Thrombosis research 2009;124(3):323-7.
2009: Leticia Nolasco; F C Gushiken; Nancy A Turner; T S Khatlani; S Pradhan; Jing-fei Dong; Joel L Moake; K V Vijayan
Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells.
Journal of thrombosis and haemostasis : JTH 2009;7(6):1009-18.
2009: Anaadriana Zakarija; Hau C Kwaan; Joel L Moake; Nicholas Bandarenko; Dilip K Pandey; June M McKoy; Paul R Yarnold; Dennis W Raisch; Jeffrey L Winters; Thomas J Raife; John F Cursio; Thanh Ha Luu; Elizabeth A Richey; Matthew J Fisher; Thomas L Ortel; Martin S Tallman; X Long Zheng; Masanori Matsumoto; Yoshihiro Fujimura; Charles L Bennett
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).
Kidney international. Supplement 2009;(112):S20-4.
2008: Yi Li; Huiwei Choi; Z Zhou; Leticia Nolasco; Henry J Pownall; J Voorberg; Joel L Moake; Jing-fei Dong
Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions.
Journal of thrombosis and haemostasis : JTH 2008;6(7):1135-43.
2007: Matthew Auton; Miguel A Cruz; Joel L Moake
Conformational stability and domain unfolding of the Von Willebrand factor A domains.
Journal of molecular biology 2007;366(3):986-1000.
2007: Joel L Moake
Journey in reverse: TTP from bedside to blood bank to bench.
Journal of clinical apheresis 2007;22(1):37-49.
2007: Tapani Ruutu; Giovanni Barosi; Richard J Benjamin; Richard E Clark; James N George; Alois Gratwohl; Ernst Holler; Massimo Iacobelli; Karim Kentouche; Bernhard Lämmle; Joel L Moake; Paul Richardson; Gérard Socié; Zella R Zeigler; Dietger Niederwieser; Tiziano Barbui
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.
Haematologica 2007;92(1):95-100.
2006: Zhenyin Tao; K Anthony; Yuandong Peng; Huiwei Choi; Leticia Nolasco; Lawrence Rice; Joel L Moake; Jing-fei Dong
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura.
Journal of thrombosis and haemostasis : JTH 2006;4(9):1931-5.
2006: N Turner; Leticia Nolasco; Zhenyin Tao; Jing-fei Dong; Joel L Moake
Human endothelial cells synthesize and release ADAMTS-13.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1396-404.
2006: M Auton; Joel L Moake
Attack of the acronyms: TTP, VWF, ADAMTS-13 and SELDI-TOF-MS.
Journal of thrombosis and haemostasis : JTH 2006;4(2):329-32.
2006: R Anand Kumar; Joel L Moake; Leticia Nolasco; Angela L Bergeron; Carol Sun; Jing-fei Dong; Larry V McIntire
Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
Biorheology 2006;43(5):681-91.
2005: Zhenyin Tao; Yuandong Peng; Leticia Nolasco; Santiago Cal; Carlos Lopez-Otin; Renhao Li; Joel L Moake; José A López; Jing-fei Dong
Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions.
Blood 2005;106(13):4139-45.
2005: Leticia Nolasco; Nancy A Turner; Aubrey Bernardo; Zhenyin Tao; Thomas G Cleary; Jing-fei Dong; Joel L Moake
Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
Blood 2005;106(13):4199-209.
2005: L Liu; Huiwei Choi; Aubrey Bernardo; Angela L Bergeron; Leticia Nolasco; C Ruan; Joel L Moake; Jing-fei Dong
Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2536-44.
2005: Aubrey Bernardo; Chalmette Ball; Leticia Nolasco; Huiwei Choi; Joel L Moake; Jing-fei Dong
Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress.
Journal of thrombosis and haemostasis : JTH 2005;3(3):562-70.
2004: Armando Tripodi; Veena Chantarangkul; M Böhm; U Budde; Jing-fei Dong; K D Friedman; M Galbusera; J-P Girma; Joel L Moake; M E Rick; Jan-Dirk Studt; P L Turecek; Pier Mannuccio Mannucci
Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas.
Journal of thrombosis and haemostasis : JTH 2004;2(9):1601-9.
2004: Joel L Moake
Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura.
Journal of thrombosis and haemostasis : JTH 2004;2(9):1515-21.
2004: Feng Li; Chester Q Li; Joel L Moake; José A López; Larry V McIntire
Shear stress-induced binding of large and unusually large von Willebrand factor to human platelet glycoprotein Ibalpha.
Annals of biomedical engineering 2004;32(7):961-9.
2004: Arnoldo Padilla; Joel L Moake; Aubrey Bernardo; Chalmette Ball; Yongtao Wang; Maneesh Arya; Leticia Nolasco; Nancy Turner; Michael C Berndt; Bahman Anvari; José A López; Jing-fei Dong
P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.
Blood 2004;103(6):2150-6.
2004: Jody L Whitelock; Leticia Nolasco; Aubrey Bernardo; Joel L Moake; Jing-fei Dong; Miguel A Cruz
ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate.
Journal of thrombosis and haemostasis : JTH 2004;2(3):485-91.
2004: Joel L Moake
Thrombotic thrombocytopenic purpura: survival by "giving a dam".
Transactions of the American Clinical and Climatological Association 2004;115():201-19.
2004: J Evan Sadler; Joel L Moake; Toshiyuki Miyata; James N George
Recent advances in thrombotic thrombocytopenic purpura.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():407-23.
2004: Joel L Moake
von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Seminars in hematology 2004;41(1):4-14.
2003: Jing-fei Dong; Joel L Moake; Aubrey Bernardo; Kazuo Fujikawa; Chalmette Ball; Leticia Nolasco; José A López; Miguel A Cruz
ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
The Journal of biological chemistry 2003;278(32):29633-9.
2003: Terzah M Horton; Jeffrey D Stone; Donald Yee; ZoAnn E Dreyer; Joel L Moake; Donald H Mahoney
Case series of thrombotic thrombocytopenic purpura in children and adolescents.
Journal of pediatric hematology/oncology 2003;25(4):336-9.
2003: S Kao; Nancy A Turner; Joel L Moake; Larry V McIntire
A novel flow cytometric analysis for platelet activation on immobilized von Willebrand factor or fibrillar collagen.
Journal of thrombosis and haemostasis : JTH 2003;1(2):347-54.
2002: Jing-fei Dong; Joel L Moake; Leticia Nolasco; Aubrey Bernardo; Wendy Arceneaux; Corie N Shrimpton; Alicia J Schade; Larry V McIntire; Kazuo Fujikawa; José A López
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
Blood 2002;100(12):4033-9.
2002: Joel L Moake
Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Archives of pathology & laboratory medicine 2002;126(11):1430-3.
2002: Joel L Moake
Thrombotic microangiopathies.
The New England journal of medicine 2002;347(8):589-600.
2002: Joerg Linneweber; T W Chow; Masaki Kawamura; Joel L Moake; Y Nosè
In vitro comparison of blood pump induced platelet microaggregates between a centrifugal and roller pump during cardiopulmonary bypass.
The International journal of artificial organs 2002;25(6):549-55.
2002: Maneesh Arya; Bahman Anvari; Gabriel M Romo; Miguel A Cruz; Jing-fei Dong; Larry V McIntire; Joel L Moake; José A López
Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers.
Blood 2002;99(11):3971-7.
2002: Feng Li; Joel L Moake; Larry V McIntire
Characterization of von Willebrand factor interaction with collagens in real time using surface plasmon resonance.
Annals of biomedical engineering 2002;30(9):1107-16.
2002: Maneesh Arya; José A López; Gabriel M Romo; Jing-fei Dong; Larry V McIntire; Joel L Moake; Bahman Anvari
Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ibalpha using optical tweezers.
Lasers in surgery and medicine 2002;30(4):306-12.
2002: Joel L Moake
Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Annual review of medicine 2002;53():75-88.
2001: Nancy A Turner; Joel L Moake; Larry V McIntire
Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.
Blood 2001;98(12):3340-5.
2001: Joel L Moake; J Evan Sadler; P Mannucci; P Ganguly
Report on the workshop: Von Willebrand factor and Thrombotic Thrombocytopenic Purpura.
American journal of hematology 2001;68(2):122-6.
2001: Joerg Linneweber; T W Chow; Tamaki Takano; Tomohiro Maeda; Kenji Nonaka; Sebastian Schulte-Eistrup; Shinji Kawahito; O Elert; Joel L Moake; Yukihiko Nosé
Direct detection of red blood cell fragments: a new flow cytometric method to evaluate hemolysis in blood pumps.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2001;47(5):533-6.
2000: Kelty R Baker; Joel L Moake
Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Current opinion in pediatrics 2000;12(1):23-8.
1998: Joel L Moake
von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura.
Clinical laboratory science : journal of the American Society for Medical Technology 1998;11(6):362-4.
1998: Joel L Moake; T W Chow
Thrombotic thrombocytopenic purpura: understanding a disease no longer rare.
The American journal of the medical sciences 1998;316(2):105-19.
1998: TW Chow; Nancy A Turner; M Chintagumpala; P D McPherson; Leticia Nolasco; Lawrence Rice; J David Hellums; Joel L Moake
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.
American journal of hematology 1998;57(4):293-302.
1998: Joel L Moake; T W Chow
Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura.
Journal of clinical apheresis 1998;13(3):126-32.
1998: Julia M Ross; Larry V McIntire; Joel L Moake; HJ Kuo; R Q Qian; Robert W Glanville; E Schwartz; Jacob H Rand
Fibrillin containing elastic microfibrils support platelet adhesion under dynamic shear conditions.
Thrombosis and haemostasis 1998;79(1):155-61.
1997: Joel L Moake
Studies on the pathophysiology of thrombotic thrombocytopenic purpura.
Seminars in hematology 1997;34(2):83-9.
1997: S G Kamat; Nancy A Turner; Konstantinos Konstantopoulos; J David Hellums; Larry V McIntire; Neal S Kleiman; Joel L Moake
Effects of Integrelin on platelet function in flow models of arterial thrombosis.
Journal of cardiovascular pharmacology 1997;29(2):156-63.
1997: Konstantinos Konstantopoulos; TW Chow; Nancy A Turner; J David Hellums; Joel L Moake
Shear stress-induced binding of von Willebrand factor to platelets.
Biorheology 1997;34(1):57-71.
1996: Michael H Kroll; J David Hellums; Larry V McIntire; Andrew I Schafer; Joel L Moake
Platelets and shear stress.
Blood 1996;88(5):1525-41.
1996: Joel L Moake; John Byrnes
Thrombotic microangiopathies associated with drugs and bone marrow transplantation.
Hematology/oncology clinics of North America 1996;10(2):485-97.
1995: J K McCrary; L H Nolasco; J David Hellums; M H Kroll; Nancy A Turner; Joel L Moake
Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress.
Annals of biomedical engineering 1995;23(6):787-93.
1995: S G Kamat; Alan D Michelson; SE Benoit; Joel L Moake; D Rajasekhar; J David Hellums; Michael H Kroll; Andrew I Schafer
Fibrinolysis inhibits shear stress-induced platelet aggregation.
Circulation 1995;92(6):1399-407.
1995: Joel L Moake
Thrombotic thrombocytopenic purpura.
Thrombosis and haemostasis 1995;74(1):240-5.
1995: H W Hsu; Michael A Belfort; S Vernino; Joel L Moake; Kenneth Moise Jr
Postpartum thrombotic thrombocytopenic purpura complicated by Budd-Chiari syndrome.
Obstetrics and gynecology 1995;85(5 Pt 2):839-43.
1995: Julia M Ross; Larry V McIntire; Joel L Moake; Jacob H Rand
Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions.
Blood 1995;85(7):1826-35.
1995: Nancy A Turner; Joel L Moake; S G Kamat; Andrew I Schafer; N S Kleiman; R Jordan; Larry V McIntire
Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
Circulation 1995;91(5):1354-62.
1994: Joel L Moake; Murali Chintagumpala; N Turner; P McPherson; L Nolasco; C Philip Steuber; P Santiago-Borrero; M Horowitz; J Pehta
Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura.
Blood 1994;84(2):490-7.
1994: Joel L Moake
Haemolytic-uraemic syndrome: basic science.
Lancet 1994;343(8894):393-7.
1993: B R Alevriadou; Joel L Moake; Nancy A Turner; Zaverio M Ruggeri; B J Folie; M D Phillips; A B Schreiber; M E Hrinda; Larry V McIntire
Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
Blood 1993;81(5):1263-76.
1993: T M Wick; Joel L Moake; Mark M Udden; Larry V McIntire
Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells.
American journal of hematology 1993;42(3):284-92.
1993: D Charba; Joel L Moake; M A Harris; J P Hester
Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies.
American journal of hematology 1993;42(3):268-77.
1992: T W Chow; J David Hellums; Joel L Moake; M H Kroll
Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
Blood 1992;80(1):113-20.
1992: Murali Chintagumpala; Richard L Hurwitz; Joel L Moake; Donald H Mahoney; C Philip Steuber
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission.
The Journal of pediatrics 1992;120(1):49-53.
1991: Michael H Kroll; T S Harris; Joel L Moake; R I Handin; Andrew I Schafer
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.
The Journal of clinical investigation 1991;88(5):1568-73.
1991: M Weinstein; Evan Vosburgh; M Phillips; N Turner; L Chute-Rose; Joel L Moake
Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.
Blood 1991;78(9):2291-8.
1991: M D Phillips; C Vu; L Nolasco; Joel L Moake
Granulocyte proteases do not process endothelial cell-derived unusually large von Willebrand factor multimers to plasma vWF in vivo.
American journal of hematology 1991;37(2):80-3.
1991: Joel L Moake
Hypercoagulable states: new knowledge about old problems.
Hospital practice (Office ed.) 1991;26(3A):31-42.
1990: Joel L Moake; P D McPherson
von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Transfusion medicine reviews 1990;4(2):163-8.
1990: Joel L Moake
Hypercoagulable states.
Advances in internal medicine 1990;35():235-47.
1990: Joel L Moake
Platelet function, surface structure and antigenicity.
Progress in clinical and biological research 1990;337():41-3.
1990: Joel L Moake
The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
Progress in clinical and biological research 1990;337():135-40.
1990: Joel L Moake
Recent observations on the pathophysiology of thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Hematologic pathology 1990;4(4):197-201.
1989: Joel L Moake; P D McPherson
Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
The American journal of medicine 1989;87(3N):9N-15N.
1989: J A Frangos; Joel L Moake; L Nolasco; M D Phillips; Larry V McIntire
Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells.
The American journal of physiology 1989;256(6 Pt 2):H1635-44.
1989: J A Katz; Joel L Moake; P D McPherson; M J Weinstein; Kenneth Moise Jr; RJ Carpenter; D J Sala
Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma.
Blood 1989;73(7):1851-8.
1989: M J Weinstein; R Blanchard; Joel L Moake; Evan Vosburgh; Kenneth Moise Jr
Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura.
British journal of haematology 1989;72(1):68-72.
1988: M D Phillips; Joel L Moake; L Nolasco; N Turner
Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
Blood 1988;72(6):1898-903.
1988: Joel L Moake
von Willebrand factor and the pathophysiology of thrombotic thrombocytopenia: from human studies to a new animal model.
Laboratory investigation; a journal of technical methods and pathology 1988;59(4):415-7.
1988: Joel L Moake; Nancy A Turner; N A Stathopoulos; L Nolasco; J David Hellums
Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.
Blood 1988;71(5):1366-74.
1987: T M Wick; Joel L Moake; Mark M Udden; S G Eskin; D A Sears; Larry V McIntire
Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow.
The Journal of clinical investigation 1987;80(3):905-10.
1987: G W Schmitt; Joel L Moake; C K Rudy; S L Vicks; R J Hamburger
Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis.
The American journal of medicine 1987;83(3):411-8.
1987: D M Peterson; N A Stathopoulos; Todd Giorgio; J David Hellums; Joel L Moake
Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.
Blood 1987;69(2):625-8.
1986: Joel L Moake; Nancy A Turner; N A Stathopoulos; L H Nolasco; J David Hellums
Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.
The Journal of clinical investigation 1986;78(6):1456-61.
1986: Joel L Moake; C K Rudy; J H Troll; M J Weinstein; N M Colannino; S L Hong; Jason A Koutcher; A J Melaragno; C E Manner
von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura.
The American journal of the medical sciences 1986;291(1):47-50.
1985: Joel L Moake; C K Rudy; J H Troll; A I Schafer; M J Weinstein; N M Colannino; S L Hong
Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine.
American journal of hematology 1985;20(1):73-9.
1985: Joel L Moake; John Byrnes; J H Troll; C K Rudy; S L Hong; M J Weinstein; N M Colannino
Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
Blood 1985;65(5):1232-6.
1985: J T Licciardello; Joel L Moake; C K Rudy; D D Karp; Waun Ki Hong
Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy.
Oncology 1985;42(5):296-300.
1984: Joel L Moake; John Byrnes; J H Troll; C K Rudy; M J Weinstein; N M Colannino; S L Hong
Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome.
Blood 1984;64(3):592-8.
1983: Joel L Moake; M J Weinstein; J H Troll; L E Chute; N M Colannino
Direct radioimmune detection in human plasma of the association between factor VIII procoagulant protein and von Willebrand factor, and the interaction of von Willebrand factor-bound procoagulant VIII with platelets.
Blood 1983;61(6):1163-73.
1982: Joel L Moake; C K Rudy; J H Troll; M J Weinstein; N M Colannino; J Azocar; R H Seder; S L Hong; D Deykin
Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.
The New England journal of medicine 1982;307(23):1432-5.
1982: M S Kuntamukkula; Joel L Moake; Larry V McIntire; P L Cimo
Effects of colchicine and vinblastine on platelet contractility and release.
Thrombosis research 1982;26(5):329-39.
1981: R A Hardwick; J David Hellums; D M Peterson; Joel L Moake; J D Olson
The effect of PGI2 and theophylline on the response of platelets subjected to shear stress.
Blood 1981;58(4):678-81.
1981: J N George; T A Reimann; Joel L Moake; R K Morgan; P L Cimo; D A Sears
Bernard-Soulier disease: a study of four patients and their parents.
British journal of haematology 1981;48(3):459-67.
1981: Joel L Moake; S S Tang; J D Olson; J H Troll; P L Cimo; P J Davies
Platelets, von Willebrand factor, and prostaglandin I2.
The American journal of physiology 1981;241(1):H54-9.
1981: R S Weinger; P L Cimo; Joel L Moake; J D Olson; M S Heller
Type IIB von Willebrand's disease: unusual response to cryoprecipitate infusion.
Annals of internal medicine 1981;94(1):47-50.
1981: R A Hardwick; J David Hellums; D M Peterson; Joel L Moake; J Olson
Effects of PGI2 and di-butyryl cyclic-AMP on platelets exposed to shear stress.
Transactions - American Society for Artificial Internal Organs 1981;27():192-6.
1980: Joel L Moake; J D Olson; J H Troll; S S Tang; T Funicella; D M Peterson
Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets.
Thrombosis research 1980;19(1-2):21-7.
1980: Joel L Moake; J D Olson; J H Troll; R S Weinger; D M Peterson; P L Cimo
Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
The Journal of laboratory and clinical medicine 1980;96(1):168-84.
1980: R S Weinger; C Rudy; Joel L Moake; J D Olson; P L Cimo
Prothrombin Houston: a dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation.
Blood 1980;55(5):811-6.
1980: J P Kirkpatrick; Larry V McIntire; Joel L Moake; P L Cimo
Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
Thrombosis and haemostasis 1980;42(5):1483-9.
1980: R A Hardwick; J David Hellums; Joel L Moake; D M Peterson; C P Alfrey
Effects of antiplatelet agents on platelets exposed to shear stress.
Transactions - American Society for Artificial Internal Organs 1980;26():179-84.
1980: R S Weinger; C Rudy; Joel L Moake; C L Conlon; P L Cimo
Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.
American journal of hematology 1980;9(3):237-48.